vs
LG化学（CHE）与RBC Bearings INC（RBC）财务数据对比。点击上方公司名可切换其他公司
RBC Bearings INC的季度营收约是LG化学的1.1倍（$461.6M vs $420.0M），LG化学净利率更高（15.8% vs 14.6%，领先1.2%），RBC Bearings INC同比增速更快（17.0% vs 3.1%），过去两年LG化学的营收复合增速更高（5.9% vs 5.6%）
LG化学是韩国最大的化工企业，总部位于韩国首尔，2021年按销售额统计为全球第九大化工企业。其前身为生产化妆品的乐喜化学工业株式会社，目前已全面转型为仅面向企业客户的B2B经营模式。
该文本实际介绍的并非RBC Bearings，而是美国多佛公司。多佛是一家工业产品综合制造商，1955年成立，总部位于伊利诺伊州当纳斯格罗夫。2021年其业务分为五大板块：工程产品、清洁能源与加注、成像与识别、泵与工艺解决方案、气候与可持续技术，是标普500成分股，在纽约证券交易所上市。
CHE vs RBC — 直观对比
营收规模更大
RBC
是对方的1.1倍
$420.0M
营收增速更快
RBC
高出13.9%
3.1%
净利率更高
CHE
高出1.2%
14.6%
两年增速更快
CHE
近两年复合增速
5.6%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $420.0M | $461.6M |
| 净利润 | $66.3M | $67.4M |
| 毛利率 | — | 44.3% |
| 营业利润率 | 20.1% | 22.3% |
| 净利率 | 15.8% | 14.6% |
| 营收同比 | 3.1% | 17.0% |
| 净利润同比 | — | 16.4% |
| 每股收益（稀释后） | — | $2.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CHERBC
| Q1 26 | $420.0M | — | ||
| Q4 25 | $639.3M | $461.6M | ||
| Q3 25 | $624.9M | $455.3M | ||
| Q2 25 | $618.8M | $436.0M | ||
| Q1 25 | $646.9M | $437.7M | ||
| Q4 24 | $411.0M | $394.4M | ||
| Q3 24 | $391.4M | $397.9M | ||
| Q2 24 | $374.6M | $406.3M |
净利润CHERBC
| Q1 26 | $66.3M | — | ||
| Q4 25 | $76.8M | $67.4M | ||
| Q3 25 | $64.2M | $60.0M | ||
| Q2 25 | $52.5M | $68.5M | ||
| Q1 25 | $71.8M | $72.7M | ||
| Q4 24 | $90.3M | $57.9M | ||
| Q3 24 | $75.8M | $54.2M | ||
| Q2 24 | $70.9M | $61.4M |
毛利率CHERBC
| Q1 26 | — | — | ||
| Q4 25 | 35.2% | 44.3% | ||
| Q3 25 | 31.5% | 44.1% | ||
| Q2 25 | 29.8% | 44.8% | ||
| Q1 25 | 33.5% | 44.2% | ||
| Q4 24 | 1.2% | 44.3% | ||
| Q3 24 | -1.2% | 43.7% | ||
| Q2 24 | -4.1% | 45.3% |
营业利润率CHERBC
| Q1 26 | 20.1% | — | ||
| Q4 25 | 15.7% | 22.3% | ||
| Q3 25 | 12.0% | 21.5% | ||
| Q2 25 | 11.0% | 23.2% | ||
| Q1 25 | 14.6% | 23.0% | ||
| Q4 24 | 27.7% | 21.7% | ||
| Q3 24 | 23.5% | 21.6% | ||
| Q2 24 | 23.5% | 24.0% |
净利率CHERBC
| Q1 26 | 15.8% | — | ||
| Q4 25 | 12.0% | 14.6% | ||
| Q3 25 | 10.3% | 13.2% | ||
| Q2 25 | 8.5% | 15.7% | ||
| Q1 25 | 11.1% | 16.6% | ||
| Q4 24 | 22.0% | 14.7% | ||
| Q3 24 | 19.4% | 13.6% | ||
| Q2 24 | 18.9% | 15.1% |
每股收益（稀释后）CHERBC
| Q1 26 | — | — | ||
| Q4 25 | $5.45 | $2.13 | ||
| Q3 25 | $4.46 | $1.90 | ||
| Q2 25 | $3.57 | $2.17 | ||
| Q1 25 | $4.86 | $2.33 | ||
| Q4 24 | $6.00 | $1.82 | ||
| Q3 24 | $5.00 | $1.65 | ||
| Q2 24 | $4.65 | $1.90 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $16.9M | $107.6M |
| 总债务越低越好 | $91.2M | $990.2M |
| 股东权益账面价值 | $848.0M | $3.3B |
| 总资产 | $1.5B | $5.1B |
| 负债/权益比越低杠杆越低 | 0.11× | 0.30× |
8季度趋势，按日历期对齐
现金及短期投资CHERBC
| Q1 26 | $16.9M | — | ||
| Q4 25 | $74.5M | $107.6M | ||
| Q3 25 | $129.8M | $91.2M | ||
| Q2 25 | $249.9M | $132.9M | ||
| Q1 25 | $173.9M | $36.8M | ||
| Q4 24 | $178.3M | — | ||
| Q3 24 | $238.5M | — | ||
| Q2 24 | $222.9M | $76.8M |
总债务CHERBC
| Q1 26 | $91.2M | — | ||
| Q4 25 | — | $990.2M | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $915.6M | ||
| Q1 25 | — | $920.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益CHERBC
| Q1 26 | $848.0M | — | ||
| Q4 25 | $979.4M | $3.3B | ||
| Q3 25 | $1.1B | $3.2B | ||
| Q2 25 | $1.2B | $3.1B | ||
| Q1 25 | $1.2B | $3.0B | ||
| Q4 24 | $1.1B | $2.9B | ||
| Q3 24 | $1.2B | $2.9B | ||
| Q2 24 | $1.2B | $2.8B |
总资产CHERBC
| Q1 26 | $1.5B | — | ||
| Q4 25 | $1.5B | $5.1B | ||
| Q3 25 | $1.6B | $5.1B | ||
| Q2 25 | $1.7B | $4.8B | ||
| Q1 25 | $1.7B | $4.7B | ||
| Q4 24 | $1.7B | $4.7B | ||
| Q3 24 | $1.8B | $4.7B | ||
| Q2 24 | $1.7B | $4.7B |
负债/权益比CHERBC
| Q1 26 | 0.11× | — | ||
| Q4 25 | — | 0.30× | ||
| Q3 25 | — | 0.34× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.30× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $88.2M | $122.1M |
| 自由现金流经营现金流 - 资本支出 | — | $99.1M |
| 自由现金流率自由现金流/营收 | — | 21.5% |
| 资本支出强度资本支出/营收 | 4.1% | 5.0% |
| 现金转化率经营现金流/净利润 | 1.33× | 1.81× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CHERBC
| Q1 26 | $88.2M | — | ||
| Q4 25 | $133.5M | $122.1M | ||
| Q3 25 | $83.4M | $88.4M | ||
| Q2 25 | $138.6M | $120.0M | ||
| Q1 25 | $32.7M | — | ||
| Q4 24 | $164.9M | $84.0M | ||
| Q3 24 | $90.5M | — | ||
| Q2 24 | $77.5M | $97.4M |
自由现金流CHERBC
| Q1 26 | — | — | ||
| Q4 25 | $117.2M | $99.1M | ||
| Q3 25 | $66.0M | $71.7M | ||
| Q2 25 | $122.8M | $104.3M | ||
| Q1 25 | $19.5M | — | ||
| Q4 24 | $152.2M | $73.6M | ||
| Q3 24 | $77.0M | — | ||
| Q2 24 | $66.5M | $88.4M |
自由现金流率CHERBC
| Q1 26 | — | — | ||
| Q4 25 | 18.3% | 21.5% | ||
| Q3 25 | 10.6% | 15.7% | ||
| Q2 25 | 19.8% | 23.9% | ||
| Q1 25 | 3.0% | — | ||
| Q4 24 | 37.0% | 18.7% | ||
| Q3 24 | 19.7% | — | ||
| Q2 24 | 17.7% | 21.8% |
资本支出强度CHERBC
| Q1 26 | 4.1% | — | ||
| Q4 25 | 2.6% | 5.0% | ||
| Q3 25 | 2.8% | 3.7% | ||
| Q2 25 | 2.6% | 3.6% | ||
| Q1 25 | 2.1% | 3.2% | ||
| Q4 24 | 3.1% | 2.6% | ||
| Q3 24 | 3.5% | 4.1% | ||
| Q2 24 | 3.0% | 2.2% |
现金转化率CHERBC
| Q1 26 | 1.33× | — | ||
| Q4 25 | 1.74× | 1.81× | ||
| Q3 25 | 1.30× | 1.47× | ||
| Q2 25 | 2.64× | 1.75× | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 1.83× | 1.45× | ||
| Q3 24 | 1.19× | — | ||
| Q2 24 | 1.09× | 1.59× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CHE
| Homecare | $371.1M | 88% |
| Inpatient | $35.9M | 9% |
| Other | $13.0M | 3% |
RBC
| Domestic | $413.3M | 90% |
| Foreign | $48.3M | 10% |
